Objective: We used the hamster cheek pouch microcirculation to investigate the effects of melatonin (ME) on ischemia reperfusion (I-R) injury by in vivo microscopy. h5E is a hormone produced by the pineal gland and is the most powerful and effective hydroxyl radical scavenger detected to date in vitro. The second aim was to determine the scavenger effect of ME in cheek pouch microcirculation when topically applying an oxygen-derived free radical generating system. Methods: Ischemia was induced by clamping the cheek pouch for 30 min followed by 30 min of reperfusion. We quantified the increase in permeability, the perfused capillary length and leukocyte adhesion by computerized methods. Microcirculation was also exposed to a hypoxanthine-xanthine oxidase (H-X) system. Results: In control hamsters I-R was associated with increased permeability, increased number of leukocytes sticking to venules, and decreased perfused capillary length. Treatment with ME completely inhibited microvascular edema formation and reduced the number of leukocytes sticking to venules after reperfusion. Moreover, ME prevented the marked decrease in perfused capillary length, preserving microvascular perfusion. ME topically applied reduced significantly the permeability increase due to H-X exposure. Conclusions: The beneficial effect of ME may be related to its antioxidant properties. These protect the endothelial barrier integrity as well as preserve microvascular blood perfusion by dysfunctions after I-R.
Introduction
The hormone, melatonin (N-acetyl-S-methoxy-tryptamine) (ME), is synthesised by the pineal gland [I] . ME affects reproductive performance in a wide variety of species as well as influences the immune system [2] . The nocturnal rise in ME levels has been associated with a reduction in the core body temperature, a modification of the levels of monoamine neurotransmitters in the brain and the onset of sleepiness [3] . ME inhibits the proliferation and growth of human breast cancer cells [4] . Recently, its scavenger activity has been documented by many authors . The hydroxyl radical scavenging potency of ME is much greater than that of other well-known free radical scavengers detected to date [8] .
Reactive oxygen metabolites are implicated in the pathogenesis of the microvascular impairment due to ischemia reperfusion (1-R) [8-101. The damage has been demonstrated to be reduced after administration of free radical scavengers, such as superoxide dismutase, deferoxamine and allopurinol [ 111.
The first objective of this study was to assess the effects of ME on microcirculatory damage during I-R. We used in vivo fluorescence microscopy in hamster cheek pouch microcirculation. This model allows the induction of complete ischemia by clamping of the blood supply for 30 min and observation over a subsequent period of 30 min of reperfusion. We quantified the microvascular permeability changes, the number of leukocytes adhering to venules, Tie for primary review 20 days. and the decrease in perfused capillary length after the period of reperfusion.
The second objective of this study was to prove the in vivo scavenger effect of ME. Therefore, we used a system generating oxygen-derived free radicals consisting of hypoxanthine-xanthine oxidase [12] (H-X), which was applied topically on the cheek pouch microcirculation.
Methods
Thirty-four male Syrian hamsters (Charles River, Calco, CO, Italy) weighing 80-100 g were divided into three groups. The first group (n = 12) was used as control (intravenously injected with vehicle-isotonic NaCl containing 0.5% ethanol); the second group (n = 12) was treated with ME (Calbiochem, La Jolla Ca, USA) by intravenous infusion lasting 5 min, 10 min before ischemia and 5 min before reperfusion (total amount 0.6 mg/lOO g b.wt., dissolved in 0.6 ml of isotonic NaCl containing 0.5% ethanol). Different dosages were used in pilot studies (0.3, 0.6, 1.2, 1.8, 2.4, 2.8 mg/lOO g b.wt.). Afterwards we chose 0.6/100 g b.wt. which was the minimum effective dosage.
The third group (n = 10) was used to assess the scavenger effect of ME in a H-X free radical generating system, locally administered on the cheek pouch.
The cheek pouch was prepared as previously reported [ll] . Briefly, the animal was anestbetised with pentobarbital (5 mg/lOO g b.wt., i.p.) (Nembutal, Abbott, Chicago, IL, USA) and tracheotomized. The carotid artery and femoral vein were catheter&d, to measure mean arterial blood pressure and to inject the fluorescent tracers and ME.
The cheek pouch was gently everted and fixed to a special stage of the microscope: a thin black blade was inserted through a small incision between the upper and lower layers of the pouch. The membrane was suffused with a 36 + 0.5"C Ringer solution (4 ml/min), with 5% CO, in 95% N,, to lower and to maintain oxygen tension at approximately 10 mmHg and a pH of 7.35. Fluorescein isothiocyanate bound to dextran MW 150000 was injected before microscopic observations. Ischemia was induced by clamping the proximal part of the cheek pouch with an atraumatic surgical clamp whose jaws were protected with sylastic rubber. The clamp was also placed far from the site of observation where the cheek pouch exits from the mouth (approximately 3-4 cm). The microcirculation was observed for a period of 30 min (ischemia period). Then the clamp was removed and the microcirculation was observed for 30 min (reperfusion period).
In the third group the cheek pouch (n = 5 hamsters) was superfused with hypoxanthine (0.96 mM) plus xanthine oxidase (0.05 unit/ml) (Sigma, St. Louis, MO, USA) dissolved in Ringer solution for 2 min. Afterwards the superfusion continued with Ringer solution. In 5 hamsters the cheek pouch was superfused with ME (1 PM dissolved in Ringer solution) and H-X for 2 min. The microvascular permeability was observed for 15 min.
Observations were made with a Leitz Grthoplan microscope, operating in incidental illumination with a Ploemopack filter block, fitted with a Leitz long working distance objective ( X 4, na 0.14, X 20, na 0.25) and a X 10 eyepiece. Epi-illumination was provided by a xenon 150-W lamp used in conjunction with the appropriate filters for fluorescein isothiocyanate bound to dextran MW 150000 (Leitz I, Ploemopack filter block), acridine red (Leitz N 2.1 Plcemopack filter block) and a heat filter (Leitz KGl). The tracer was injected intravenously (50 mg/lOO g b.wt., as 5% w/v solution in 5 min) and televised with a COHU 5253 SIT low light level camera, observed from a Sony PVM 122 CE monitor and recorded by a Sony U-Matic VO 5800 PS video recorder.
Mean arterial blood pressure (MAP) (Statham PD 23 transducer connected to a catheter in the carotid artery) and heart rate (HR) (via ECG leads) were monitored and continuously recorded by a Honeywell RM 300 monitor interfaced to an IBM XT 286 personal computer.
The increase in permeability was quantified as average grey levels of the fluorescent areas in the microscopic field before ischemia and after the period of I-R, as previously described [ 11 I. The microscopic images were televised and digitised in real time, using a custom-designed imageprocessing system based on a Matrox PIP-640 B extension board installed in a HP Vectra RS/25 C computer and stored. The average grey levels, ranging from 0 to 255, were determined in a window of 500 X 500 pm. The increase in permeability was calculated and reported as normalised grey levels: NGL = (I -Z,)/Z,, where I is the average grey value after the I-R period and Z, is the average grey level value before the ischemia period.
To stain leukocytes the animals received an intravenous injection of acridine red (Chroma, Stuttgart, FRG) (1 mg/lOO g b.wt. in 0.5 ml) and a supplemental injection (final ,volume 0.5 ml/ 100 g/h) throughout the experiment. The sticking leukocytes (expressed as number/100 pm of venule length) were counted before the start of ischemia and after I-R (overall time-period: 1 min). Single venules with diameters of 16 + 8 pm and lengths > 250 pm were selected for study.
Vessel diameter was measured using a computerised technique [ 131. The vessels were observed with a 20 X objective lens. The sequences of interest were digit&d in real time, during videotape playbacks. The vessel under study was aligned vertically and its diameter was measured by positioning a window across its lumen. An edge detection algorithm detected the inside wall of the blood vessel and computed the average diameter within the window.
The number of perfused capillaries was evaluated by measuring the perfused capillary length using a computerised technique [ 111. The images were digitised in real time during playback of the experiments. The perfused capillaries were outlined by a light pen and the overall length automatically calculated in a discrete area of 550 x 550 pm.
All reported values are means f SD. A statistical package, SPSS/PC + , implemented for a HP 486 computer was used. The distribution of data was determined by the Kolmogorov-Smimov test for small size of samples. All the data presented normal distributions; therefore we used the Student r-test, paired or unpaired, when appropriate. To compare the percentage changes in perfused capillary length we used the Mann-Whitney test. ANOVA and Scheffk's post-hoc test were employed for multiple comparisons. Statistical significance was set at P < 0.05.
Results
In preliminary studies the dosages of 0.3 mg/lOO g b.wt. (n = 5 hamsters) did not provide complete protection against the increase in microvascular permeability and leukocyte adhesion even though the capillary perfusion improved in comparison with the control group. The dosage of 0.6 mg/lOO g b.wt. was the minimum dosage that appeared to give.complete protection against a permeability increase. With the higher dosages we noted an effect on MAP that decreased significantly within 5 min of drug injection while the microvascular impairments were prevented. Therefore, we chose the dosage of 0.6 mg/lOO g b.wt. which did not appear to alter physiological parameters.
3.1. The effects of ME on permeability changes
In the control group ischemia caused increased permeability in postcapillary and collecting venules. Reperfusion induced a further increase in microvascular permeability in postcapillary and collecting venules (Fig. 1) . Permeability, expressed as normalised grey level (NGL), was 0.30 f 0.13 NGL after ischemia; there was a steep increase to 0.52 f 0.07 NGL after reperfusion (P < 0.01).
The group of animals treated with ME showed no increase in permeability during ischemia or during reperfusion (Fig. 2) . The permeability value was 0.06 f 0.02 NGL after ischemia and 0.09 f 0.04 NGL after reperfusion. Both values were significantly different from controls (P < 0.01). All the results are summarised in Table 1. 3.2. The effects of ME on leukocyte adhesion
In the control group leukocytes adhered markedly to venules (diameter: 16 f 8 pm>. The leukocytes were 0.9 f 0.2 and 9.1 If: l.O/lOO pm of venular length before ischemia and after reperfusion (P < 0.011, respectively. ME reduced significantly the number of adherent leukocytes after reperfusion when compared with controls: 1 .l f 0.3 and 1.5 f 0.2/100 pm of venular length before ischemia and after reperfusion (P < 0.011, respectively. Furthermore, we did not observe capillary plugging by leukocytes.
The effects of ME on capillary length
The perfused capillary length was 9055 f 747 pm before &hernia and was reduced by 61 f 4.5% of the baseline value after reperfusion (P < 0.01) in control animals.
In the group treated with ME the perfused capillary length was 8790 A-599 pm before ischemia and was reduced by 5 f. 2.5% compared with the baseline value after reperfusion. The reperfusion restored blood flow in almost all capillaries immediately after the period of ischemia.
The effects of ME on MAP and HR
MAP showed a tendency to decrease within 3 f 1 min of the injection of ME: under baseline conditions MAP was 95 + 8 mmHg, then decreased to 89 f 8 mmHg. HR also decreased after injections. Prior to the injection of ME HR was 220 f 30 and after the injection was significantly decreased to 160 + 23 beats/min, P < 0.05. In the control group MAP and HR did not change significantly during the experiments.
The effects of ME on the H-X system
The cheek pouch microcirculation superfused with H-X showed arteriolar constriction and increased permeability in venules. The vasoconstriction appeared in 2-3 min and arterioles decreased their diameter by 48 f 8% (P < 0.01 vs. baseline value 20 f 4 pm, n = 10 vessels). The permeability increase in 5-10 min was marked in postcapillary and collecting venules (0.25 _+ 0.05 NGL). Furthermore, the local administration of ME prior to the application of H-X abolished the permeability increase (0.012 f 0.004 NGL, 95 + 2% decrease in permeability compared with animals treated locally with H-X, P < 0.01). Furthermore, treatment with ME prevented arteriolar constriction, causing no impairment in microvascular perfusion.
Discussion
Our principal finding is that ME completely prevented microvascular damage induced by I-R. ME inhibited permeability increase, decreased the number of adhering leukocytes to venules and avoided alteration in capillary perfusion. Furthermore, our results show the scavenger effects of ME when topically applied, reducing the damage induced by an oxygen-derived free radical generating system. Therefore, the beneficial effects of ME during I-R may involve mechanisms that are dependent on processes related to free radical generation. This is the first evidence of ME protective effects in in-vivo models of I-R injury and oxidative stress in the microcirculation.
Oxygen free radicals are important mediators of I-R injury. The source of superoxide and other radicals may be cytochrome oxidase in mitochondria and possibly xanthine oxidase in endothelial cells in different tissues [14] . In particular, its main production may occur during the reperfusion phase [15] . Furthermore, it was shown also that during the first 5 min of ischemia there is already a significant production of free radicals that can react rapidly with oxygen, exacerbating the oxygen deficit and impairing bioenergetics [ 11 ,161.
Our results in control hamsters indicate that ischemia produced microvascular permeability that was maximal after reperfusion. Furthermore, we observed that H-X-derived free radicals, topically produced, induced an increase in permeability in hamster cheek pouch postcapillary and collecting venules. The changes in permeability were the first signs of developing microvascular damage and were observed in the same vessels as those affected by ischemia reperfusion injury. The damage was completely suppressed by topically applied ME.
In hamsters treated with ME, edema formation was completely prevented during I-R. ME anti-oxidative properties may reduce oxygen-derived free radicals that are known to induce lipid peroxidation of membranes and increased permeability [17] . This protective effect may be due to the ME indole structure that has been shown to scavenge free radicals, in particular the hydroxyl radical, thereby giving rise to new structures that are resonancestabilised and no longer toxic to macromolecules [5] . ME acts as an endogenous antioxidant with activity superior to that of glutathione, mannitol, vitamin C and vitamm E [6, 8] . Furthermore, ME supplementation appears to preserve glutathione, ascorbate and a-tocopherol levels in their reduced forms [ 181. Pierrefiche et al. [19] found that the scavenger effect of ME dependent on the indole structure is related to its hepatic metabolite, 6-hydroxy-melatonin. Further studies are required to demonstrate if the effects observed in our study are related to this metabolite. However, the topical application of ME to the cheek pouch microcirculation inhibited the damage induced by the H-X system.
Ianas et al. [20] showed that ME in lower doses has an antioxidant effect in vitro while in higher doses it has a dose-dependent pro-oxidant effect. The microvascular impairment was prevented with higher doses tested in our pilot study during I-R, but there was a significant effect on MAP. In addition, when ME was administered only before ischemia or before reperfusion, less significant protection was detected compared with the complete protection obtained with ME treatment before and after ischemia.
The half-life of ME injected intraarterially is approximately 20 min [21] and is related to the amount injected and to the presence of anesthesia. The higher dosage of ME reduces the half-life to 3-4 min [22] and the anesthesia with pentobarbital increases the half-life up to 40 min [21] . Therefore, taking into account these complex interferences, it is possible to suggest that the plasma concentration in our experiments is in the order of micrograms per milliliter, at the end of the period of I-R, which is always higher than the physiological concentration of ME (45 pg/ml) [Zl. H owever, the lowest dose of ME did not completely preserve the microvessels from an increase in permeability and leukocyte adhesion due to I-R.
It may be hypothesised that there is direct protection of vascular endothelium by ME, for ME easily diffuses across cell membranes because of its lipophilic nature [18] . Indeed, every cell compartment in the vasculature may be protected by ME from endothelial dysfunction during I-R and oxidative stress.
In control hamsters our data indicate that leukocytes adhered significantly to the venules during reperfusion. Leukocytes have been implicated in playing a fundamental role in postischemic reperfusion injury to various tissues [23, 24] ; indeed, I-R-induced formation of reactive oxygen metabolites increases leukocyte adhesion and microvascular permeability with concomitant edema formation [24, 25] . It has been demonstrated that leukocytes after adhesion to endothelium enhance permeability or produce cell injury. Leukocytes damage endothelial cells by releasing reactive oxygen metabolites, such as superoxide, hypochlorous acid, or N-chloramines, or by secretion of certain proteases [26] .
The inhibitory effect on leukocyte-endothelium adhesion exerted by ME can be attributed to its scavenger effects on oxidants (perhaps endothelial-derived superoxide formation) produced during I-R. Therefore, ME can act on different phases of production of oxidative stress during the I-R sequence of events.
Leukocytes have been observed to accumulate in the ischemic tissue, suggesting that they cause capillary plugging [27] and contribute to the progressive reduction of capillary perfusion (the no reflow phenomenon). In the control group there was a marked and significant decrease of perfused capillaries.The anti-adhesion effect of ME appears to prevent leukocyte-mediated injury to endothelium and could be important in preserving tissue perfusion.
Many authors have shown that in the maintenance of capillary perfusion it is important to consider the intracellular edema formation that causes capillary obstruction [24, 28] . Our previous observations indicate that increases in permeability and leukocyte plugging play different roles in the development of the no reflow phenomenon, where changes in extravascular compression due to microvessel leakage become prominent [ 111. Therefore, the protective effect exerted by ME on permeability increase can contribute to the recovery of capillary perfusion.
Nevertheless, it is important that ME maintains local perfusion because several agents that protect against the increase in permeability or leukocyte adherence do not improve perfusion. Allopurinol, an inhibitor of xanthine oxidase and an antioxidant, decreased microvascular permeability, but it was not sufficient to ensure the maintenance of capillary flow during I-R [ll]. Adenosine and calcium antagonists reduced partly the permeability increase and blood flow recovered in many capillaries [ 111.
Furthermore, it has been established that endothelial cells exposed to hypoxia reoxygenation produce large amounts of superoxide anions [29, 30] that can result in alterations of cellular membranes characterised by a higher calcium influx. In addition, the activation of cellular processes that produce inflammatory mediators is partially controlled by influx of extracellular Ca2'. Chen et al. [31] found that ME treatment, before alloxan administration in rats, partially prevents alloxan toxicity to Ca'+-stimulated ATPase in cardiac sarcolemma. Ca" pump activity is usually depressed during alloxan treatment whereas the density of voltage-sensitive calcium channels is increased. The toxicity of alloxan is related to oxygen free radicals.
Therefore, the protective effects of ME are fundamentally related to its scavenger activity, but they may involve the capacity to save microvascular perfusion during I-R. Probably these effects avoid further damage mechanisms mediated by altered blood flow to the microcirculation.
Our data show a significant reduction of HR and a trend for MAP to decrease. This may indicate a modulating effect of ME on calcium influx in different cardiac and vascular muscle cells that is not necessarily related to free radical effects. In addition, receptors of ME are localised in the caudal artery and in the arteries that form the circle of Willis in rats. ME may cause changes in the tone of these vessels and circulatory adjustments that are believed to be involved in thermoregulation [32] . Further experiments are obviously needed to determine the mechanisms that potentially can mediate different effects of ME acting centrally or locally on vascular muscle cells to regulate blood pressure.
In conclusion, our results show that ME can act as an endogenous antioxidant and its treatment provides complete protection against edema formation and inhibits leukocyte adhesion in &hernia reperfusion injury. The protective effect of MIS is primarily related to preserving microvascular perfusion since it inhibits permeability increase and avoids extravascular compression as interstitial fluid accumulates in the extracellular space.
